All-trans retinoic acid and interferon-α increase CD38 expression on adult T-cell leukemia cells and sensitize them to T cells bearing anti-CD38 chimeric antigen receptors

被引：15

作者：

Mihara, K. ^{[1
]}

Yoshida, T. ^{[1
]}

Ishida, S. ^{[1
]}

Takei, Y. ^{[2
]}

Kitanaka, A. ^{[3
]}

Shimoda, K. ^{[3
]}

Morishita, K. ^{[4
]}

Takihara, Y. ^{[5
]}

Ichinohe, T. ^{[1
]}

机构：

[1] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Hematol & Oncol, Hiroshima, Japan

[2] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4648601, Japan

[3] Miyazaki Univ, Fac Med, Dept Internal Med, Div Gastroenterol & Hematol, Miyazaki, Japan

[4] Miyazaki Univ, Div Tumor & Cellular Biochem, Dept Med Sci, Fac Med, Miyazaki, Japan

[5] Hiroshima Univ, Dept Stem Cell Biol, Res Inst Radiat Biol & Med, Hiroshima, Japan

来源：

BLOOD CANCER JOURNAL | 2016年 / 6卷

关键词：

NON-HODGKIN-LYMPHOMA; MYELOMA CELLS; IMMUNOTHERAPY; LEUKEMIA/LYMPHOMA;

D O I：

10.1038/bcj.2016.30

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：e421 / e421

页数：4

共 15 条

[1] Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes [J].

Bazarbachi, Ali ;

Plumelle, Yves ;

Ramos, Juan Carlos ;

Tortevoye, Patricia ;

Otrock, Zaher ;

Taylor, Graham ;

Gessain, Antoine ;

Harrington, William ;

Panelatti, Gerard ;

Hermine, Olivier .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (27) :4177-4183

[2] CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia [J].

Brentjens, Renier J. ;

Davila, Marco L. ;

Riviere, Isabelle ;

Park, Jae ;

Wang, Xiuyan ;

Cowell, Lindsay G. ;

Bartido, Shirley ;

Stefanski, Jolanta ;

Taylor, Clare ;

Olszewska, Malgorzata ;

Borquez-Ojeda, Oriana ;

Qu, Jinrong ;

Wasielewska, Teresa ;

He, Qing ;

Bernal, Yvette ;

Rijo, Ivelise V. ;

Hedvat, Cyrus ;

Kobos, Rachel ;

Curran, Kevin ;

Steinherz, Peter ;

Jurcic, Joseph ;

Rosenblat, Todd ;

Maslak, Peter ;

Frattini, Mark ;

Sadelain, Michel .

SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (177)

[3] Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias [J].

Brentjens, Renier J. ;

Riviere, Isabelle ;

Park, Jae H. ;

Davila, Marco L. ;

Wang, Xiuyan ;

Stefanski, Jolanta ;

Taylor, Clare ;

Yeh, Raymond ;

Bartido, Shirley ;

Borquez-Ojeda, Oriana ;

Olszewska, Malgorzata ;

Bernal, Yvette ;

Pegram, Hollie ;

Przybylowski, Mark ;

Hollyman, Daniel ;

Usachenko, Yelena ;

Pirraglia, Domenick ;

Hosey, James ;

Santos, Elmer ;

Halton, Elizabeth ;

Maslak, Peter ;

Scheinberg, David ;

Jurcic, Joseph ;

Heaney, Mark ;

Heller, Glenn ;

Frattini, Mark ;

Sadelain, Michel .

BLOOD, 2011, 118 (18) :4817-4828

[4] Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study [J].

Cruz, Conrad Russell Y. ;

Micklethwaite, Kenneth P. ;

Savoldo, Barbara ;

Ramos, Carlos A. ;

Lam, Sharon ;

Ku, Stephanie ;

Diouf, Oumar ;

Liu, Enli ;

Barrett, A. John ;

Ito, Sawa ;

Shpall, Elizabeth J. ;

Krance, Robert A. ;

Kamble, Rammurti T. ;

Carrum, George ;

Hosing, Chitra M. ;

Gee, Adrian P. ;

Mei, Zhuyong ;

Grilley, Bambi J. ;

Heslop, Helen E. ;

Rooney, Cliona M. ;

Brenner, Malcolm K. ;

Bollard, Catherine M. ;

Dotti, Gianpietro .

BLOOD, 2013, 122 (17) :2965-2973

[5] RAPID INDUCTION OF CD38 ANTIGEN ON MYELOID-LEUKEMIA CELLS BY ALL-TRANS-RETINOIC ACID [J].

DRACH, J ;

ZHAO, SR ;

MALAVASI, F ;

MEHTA, K .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (02) :545-550

[6] Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia [J].

Grupp, Stephan A. ;

Kalos, Michael ;

Barrett, David ;

Aplenc, Richard ;

Porter, David L. ;

Rheingold, Susan R. ;

Teachey, David T. ;

Chew, Anne ;

Hauck, Bernd ;

Wright, J. Fraser ;

Milone, Michael C. ;

Levine, Bruce L. ;

June, Carl H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (16) :1509-1518

[7] B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells [J].

Kochenderfer, James N. ;

Dudley, Mark E. ;

Feldman, Steven A. ;

Wilson, Wyndham H. ;

Spaner, David E. ;

Maric, Irina ;

Stetler-Stevenson, Maryalice ;

Phan, Giao Q. ;

Hughes, Marybeth S. ;

Sherry, Richard M. ;

Yang, James C. ;

Kammula, Udai S. ;

Devillier, Laura ;

Carpenter, Robert ;

Nathan, Debbie-Ann N. ;

Morgan, Richard A. ;

Laurencot, Carolyn ;

Rosenberg, Steven A. .

BLOOD, 2012, 119 (12) :2709-2720

[8] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells [J].

Mihara, K. ;

Bhattacharyya, J. ;

Kitanaka, A. ;

Yanagihara, K. ;

Kubo, T. ;

Takei, Y. ;

Asaoku, H. ;

Takihara, Y. ;

Kimura, A. .

LEUKEMIA, 2012, 26 (02) :365-367

[9] Synergistic and persistent effect of T-cell immunotherapy with anti-CD19 or anti-CD38 chimeric receptor in conjunction with rituximab on B-cell non-Hodgkin lymphoma [J].

Mihara, Keichiro ;

Yanagihara, Kazuyoshi ;

Takigahira, Misato ;

Kitanaka, Akira ;

Imai, Chihaya ;

Bhattacharyya, Joyeeta ;

Kubo, Takanori ;

Takei, Yoshifumi ;

Yasunaga, Shin'ichiro ;

Takihara, Yoshihiro ;

Kimura, Akiro .

BRITISH JOURNAL OF HAEMATOLOGY, 2010, 151 (01) :37-46

[10] Activated T-cell-mediated Immunotherapy With a Chimeric Receptor Against CD38 in B-cell Non-Hodgkin Lymphoma [J].